Trium Analysis Online
Trium Analysis Online GmbH is a Munich-based medical technology company that builds certified fetal monitoring software (Trium CTG Online) and a wearable accelerometer (actibelt) for clinical trials, serving hospitals, pharmaceutical sponsors, CROs, and space agencies globally.
- Company typePrivate
- Founded1999
- HeadquartersMünchen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Trium Analysis Online does
Trium Analysis Online GmbH is a privately held Munich-based medical technology company founded in 1999 that operates two distinct product lines targeting regulated healthcare and clinical research markets. Trium CTG Online is a Class IIB CE-certified, patented web-based central station for cardiotocography (CTG) that connects to fetal monitors across hospital networks and provides real-time fetal surveillance, alerting, partogram documentation, electronic archiving, and integration with leading Maternity Information Systems and HIS/EMR platforms. Actibelt, introduced in 2005, is a wearable device that conceals a high-tech 3D-accelerometer (plus gyroscope, magnetometer, and pressure sensors) inside a belt buckle, records multi-sensor data at up to 100Hz for up to three months on a single battery, and feeds validated activity parameters — including real-world walking speed, distance, gait, and mediolateral body sway — into clinical-trial outcome sets aligned with EMA/FDA expectations.
The company's technology foundation rests on roughly 20 years of proprietary biosignal-analysis algorithm development and validation in regulatory contexts, combined with a certified quality management system (ISO 13485:2016 / EN ISO 13485:2016), MDR certification, SGS-certified hardware for the US and Canada (RCT2 and RCT3), CE marking, and patent protection on the CTG platform. Both products are positioned around objective, bias-free measurement to replace questionnaire-based or rater-dependent endpoints, with actibelt additionally validated through feasibility studies and operational deployments with NASA, ESA, DLR, and Roscosmos since 2007, including a 2024 deployment on the International Space Station during Axiom Mission 4.
Commercially, Trium Analysis Online generates revenue through a mix of recurring software licensing, installation, and support for CTG deployments — sold in Germany through GE Healthcare GmbH as exclusive channel partner with dedicated service contacts — and hardware-plus-services contracts for actibelt deployments with pharmaceutical sponsors, CROs, and research institutions across more than a dozen countries in Europe, North America, Asia-Pacific, and Latin America. The company is owner-managed by three managing directors (Yehoshua Chmiel, Jonathan Chmiel, and Prof. Dr. Martin Daumer), has not raised external institutional capital, and operates with an 11–50 employee footprint with no publicly disclosed financials.
Trium Analysis Online firmographics
Firmographics- Name
- Trium Analysis Online
- Legal name
- Trium Analysis Online GmbH
- Website
- https://trium.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Trium Analysis Online GmbH is a Munich-based medical technology company that builds certified fetal monitoring software (Trium CTG Online) and a wearable accelerometer (actibelt) for clinical trials, serving hospitals, pharmaceutical sponsors, CROs, and space agencies globally.
- Ownership category
- akta.pro rank
Trium Analysis Online industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)
- akta.pro secondary industries
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
Keywords
Where Trium Analysis Online is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Trium Analysis Online business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Medical Device Software (Trium CTG Online): Class IIB CE-certified fetal monitoring software sold to hospitals and maternity departments. Revenue from software licensing, installation, and support services through GE Healthcare partnership.
- Wearable Hardware (actibelt): Sale and deployment of actibelt wearable devices for clinical trials. Includes hardware, software configuration tools, data management, and consulting services.
- Clinical Trial Services: End-to-end clinical trial accelerometry services including device deployment, data collection, analysis, and regulatory-ready reporting for EMA/FDA submissions.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Trium Analysis Online product offering
Product offeringCore offering
Trium Analysis Online develops and sells regulated medical device technology for two markets: Trium CTG Online is a patented, Class IIB CE-certified web-based central station that aggregates fetal monitoring data from any bedside monitor across the hospital network for surveillance, alerting, and archiving; actibelt is a wearable 3D-accelerometer device used in clinical trials to objectively measure patient physical activity and walking ability. Both lines are supported by proprietary biosignal analysis algorithms, ISO 13485-certified development, and cloud-based data management services.
Product overview
Trium Analysis Online GmbH offers two distinct medical technology products: Trium CTG Online is a web-based fetal monitoring central station software for maternity departments that connects to fetal monitors and provides real-time surveillance, alerting, and diagnostic support. The actibelt is a wearable 3D-accelerometer device worn in a belt buckle designed for clinical trial activity monitoring. Both products operate independently but share the company's focus on medical device compliance and integration with hospital IT infrastructure.
Differentiator
Problem solved
Functional benefit
Brands
- Trium CTG Online: A Class IIB CE-certified and patented central station software system for fetal monitoring in maternity departments, featuring real-time CTG tracing, alerts, partogram documentation, and web-based access.
- actibelt
Products and services
- Trium CTG Online Class IIB CE-certified and patented central station software for fetal monitoring in hospital maternity departments. Connects to any fetal monitor via hospital network infrastructure, providing real-time CTG traces, alerts for abnormal fetal vital signs, partogram documentation, and integration with HIS/EMR and maternity information systems such as GE ViewPoint.
- actibelt
Quantifiable outcome
- Up to 50 patients can be equipped per day per centre
- +2 more outcomes
Companies that use Trium Analysis Online
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Trium Analysis Online technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability1 record
Feature4 records
Trium Analysis Online partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- DLR (German Aerospace Center)coreDLR Institute of Aerospace Medicine collaboration for Muscle and Bone Metabolism research. Feasibility studies starting in 2007 for activity monitoring under microgravity and partial gravity environments.
- ESA (European Space Agency)coreEuropean Space Agency collaboration for feasibility studies starting in 2007 on activity monitoring of astronauts under partial gravity with 3D accelerometer.
- NASAcoreNASA Exploration Medical Capability Group (ExMC) evaluation of actiBelt in microgravity environment starting June 2007. Actibelt deployed on ISS missions including Axiom Mission 4 in 2024.
- GE HealthcarecoreGE Healthcare GmbH serves as the sales partner for Trium CTG Online products in Germany, handling both sales and service/support functions. They provide local contact numbers and email support for customers.
- TUM (Technical University of Munich)coreCollaboration with TUM for development of specialized simulation environments, particularly in Muscle and Bone Metabolism research at the Institute of Aerospace Medicine.
- SGSminorSGS (Societe Generale de Surveillance) provides voluntary certification for RCT2 and RCT3 devices to ensure compliance with national safety standards in the US and Canada. EMC and electrical safety certification provided.
- BSI GroupminorBritish Standards Institution provides certification for medical device compliance including MDR certificates MD 572313 and MDR 776256.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Trium Analysis Online competitors and assessment
Company assessmentDirect peers
- ActiGraph: ActiGraph is the most direct competitor for actibelt in clinical trial accelerometry. It provides FDA-cleared wearable activity monitors and validated digital endpoints for pharmaceutical trials, overlapping strongly with Trium's clinical trial segment.
- activinsights: activinsights offers the BandUCL and wearable activity monitors for clinical and research trials, targeting the same pharmaceutical/CRO customer base as actibelt, including objective physical activity endpoints.
- CamNTech: CamNTech provides research-grade wearable actigraphy devices (MotionWatch, Actiheart) for clinical trials and academic research. Comparable to actibelt in the wearable accelerometry for clinical research segment.
Others
- Clinical ink: Clinical ink provides eCOA/ePRO and digital endpoint platforms for clinical trials. While not a wearable competitor, it is comparable as an adjacent digital health vendor serving the same pharmaceutical trial sponsor customers.
Emerging players
- iMotions: iMotions provides biosensor integration and analysis platforms for human behavior research, including wearable sensors in clinical and academic studies. Comparable to actibelt's biosignal analysis capabilities.
- Empatica: Empatica makes clinical-grade wearables (EpiMonitor, Embrace) with FDA clearances for continuous biosignal monitoring in neurology and clinical trials. Comparable to actibelt in clinical-grade wearable biosignal capture for pharma studies.
Broad incumbents
- Mindray: Mindray is a major global patient and fetal monitoring vendor. Its broader portfolio of monitors and strong price positioning in Europe make it a relevant competitor for Trium CTG Online in cost-sensitive tenders.
- Hillrom (Baxter): Hillrom (now part of Baxter) markets the Welch Allyn and fetal monitoring product lines, representing a broad incumbent in maternal-fetal monitoring with hospital-wide distribution.
- GE HealthCare: GE HealthCare is both Trium's core channel partner for CTG Online in Germany and a competitor via its Corometrics maternal-fetal monitoring line. Also owns ViewPoint, which Trium's CTG Online integrates with.
- Philips: Philips is a global incumbent in maternal-fetal monitoring (Avalon FM series) and patient monitoring. It competes with Trium CTG Online in hospital obstetrics departments and represents the largest competitive threat in the fetal monitoring space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Trium Analysis Online compliance and trust
Trust signalCompliance4 records
Trium Analysis Online financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trium Analysis Online leadership team
Management profileNumber of profiles
Profiles3 records
Trium Analysis Online funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trium Analysis Online M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trium Analysis Online
What does Trium Analysis Online do?
Trium Analysis Online develops and sells regulated medical device technology for two markets: Trium CTG Online is a patented, Class IIB CE-certified web-based central station that aggregates fetal monitoring data from any bedside monitor across the hospital network for surveillance, alerting, and archiving; actibelt is a wearable 3D-accelerometer device used in clinical trials to objectively measure patient physical activity and walking ability. Both lines are supported by proprietary biosignal analysis algorithms, ISO 13485-certified development, and cloud-based data management services.
Is Trium Analysis Online a public or private company?
Trium Analysis Online is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Trium Analysis Online founded?
Trium Analysis Online was founded in 1999. It employs 11 to 50 people.
Where is Trium Analysis Online based?
Trium Analysis Online is headquartered in München, Germany, in the Europe region.
How does Trium Analysis Online make money?
Three revenue lines are on record. Medical Device Software (Trium CTG Online) is the primary driver. The others are wearable Hardware (actibelt) and clinical Trial Services.
Who are Trium Analysis Online's main competitors?
Direct peers on record are ActiGraph, activinsights and CamNTech. Clinical ink is listed as an others. Emerging players are iMotions and Empatica. Broad incumbents are Mindray, Hillrom (Baxter), GE HealthCare and Philips.
Does Trium Analysis Online have an API?
No public API is recorded for Trium Analysis Online.
What industry is Trium Analysis Online in?
Trium Analysis Online's product category is Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 339112 and its SIC code is 3841.